Psychiatric Emergencies, The Neuroleptic Malignant and Serotonin Syndromes
Emerg Med Clin North Am 18:317-325, Carbone,J.R., 2000
Missed Neuroleptic Malignant Syndrome
BMJ 304:831-832, Renwick,D.S.,et al, 1992
Dantrolene Sodium and Hepatic Injury
Neurol 40:1427-1432, Chan,C.H., 1990
Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989
Phenelzine Toxicity Responsive to Dantrolene
Neurol 37:865-867, Verrilli,M.R.,et al, 1987
Neuroleptic Malignant Syndrome
NEJM 313:163-166, Guze,B.H.,et al, 1985
The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983
Neuroleptic Malignant Syndrome:Response to Dantrolene Sodium
Ann Int Med 98:183-184, May,D.C.,et al, 1983
Beneficial Effects of Dantrolene in the Treatment of Neuroleptic Malignant Syndrome:A Report of Two Cases
Neurol 33:516-518, Goulon,M.,et al, 1983
Neuroleptic Malignant Syndrome:Successful Treatment with Dantolene & Bromocriptine
Ann Neurol 14:89-90, Granato,J.E.,et al, 1983
Treatment Of Neuroleptic Malignant Syndrome With Dantrolene
Lancet 2:49-50, Goekoop,J.G.,et al, 1982
Spasticity
et al (Part 1 & 2) NEJM 304:28-33, 96-99., Young,R.R., 1981
A Form of Chorea That Responds to Dantrolene Sodium
Neurol 29:163l-1632, Feit,H., 1979
Pleuropericardial Reaction to Treatment With Dantrolene
JAMA 242:2772--2774, Petusevsky,M.L.,et al, 1979
Important Advances in Clinical Medicine
West J Med 123:128, Mosier,J.M.,et al, 1975
Dantrium-Hepatic Failure
5 Jan, 1975, Letter, Eaton Laboratories., Hailey,F.J., 1975